March 29 (Reuters) - Intellipharmaceutics International Inc IPCI.TO :
* U.S. FDA ACKNOWLEDGES RECEIPT OF INTELLIPHARMACEUTICS' RESUBMISSION OF OXYCODONE ER NEW DRUG APPLICATION, DEEMS IT A COMPLETE RESPONSE
* INTELLIPHARMACEUTICS INTERNATIONAL INC - FDA DESIGNATES AUGUST 28, 2019 AS GOAL DATE FOR REVIEW